397 related articles for article (PubMed ID: 25871646)
21. Systems pharmacology in drug discovery and therapeutic insight for herbal medicines.
Huang C; Zheng C; Li Y; Wang Y; Lu A; Yang L
Brief Bioinform; 2014 Sep; 15(5):710-33. PubMed ID: 23736100
[TBL] [Abstract][Full Text] [Related]
22. The scientific basis of rational prescribing. A guide to precision clinical pharmacology based on the WHO 6-step method.
Rongen GA; Marquet P; van Gerven JMA;
Eur J Clin Pharmacol; 2021 May; 77(5):677-683. PubMed ID: 33210160
[TBL] [Abstract][Full Text] [Related]
23. [Research on pharmacometabolomics].
Zhang ZX; Gao XY
Zhongguo Zhong Yao Za Zhi; 2018 Mar; 43(6):1093-1098. PubMed ID: 29676113
[TBL] [Abstract][Full Text] [Related]
24. How pharmacogenomics (PG) are changing practice: implications for prescribers, their patients, and the healthcare system (PG series part I).
Preskorn SH; Hatt CR
J Psychiatr Pract; 2013 Mar; 19(2):142-9. PubMed ID: 23507814
[TBL] [Abstract][Full Text] [Related]
25. Biomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory science.
Zhang C; Hong H; Mendrick DL; Tang Y; Cheng F
Biomark Med; 2015; 9(11):1241-52. PubMed ID: 26506997
[TBL] [Abstract][Full Text] [Related]
26. Metabolomics: integration of a new "omics" with clinical pharmacology.
James LP
Clin Pharmacol Ther; 2013 Nov; 94(5):547-51. PubMed ID: 24145711
[TBL] [Abstract][Full Text] [Related]
27. Fundamentals of Pharmacogenetics in Personalized, Precision Medicine.
Valdes R; Yin DT
Clin Lab Med; 2016 Sep; 36(3):447-59. PubMed ID: 27514461
[TBL] [Abstract][Full Text] [Related]
28. Review of applications and challenges of quantitative systems pharmacology modeling and machine learning for heart failure.
Cheng L; Qiu Y; Schmidt BJ; Wei GW
J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):39-50. PubMed ID: 34637069
[TBL] [Abstract][Full Text] [Related]
29. Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.
Bai JPF; Earp JC; Pillai VC
AAPS J; 2019 Jun; 21(4):72. PubMed ID: 31161268
[TBL] [Abstract][Full Text] [Related]
30. Systems medicine: evolution of systems biology from bench to bedside.
Wang RS; Maron BA; Loscalzo J
Wiley Interdiscip Rev Syst Biol Med; 2015; 7(4):141-61. PubMed ID: 25891169
[TBL] [Abstract][Full Text] [Related]
31. Systems Biology of Metabolism: A Driver for Developing Personalized and Precision Medicine.
Nielsen J
Cell Metab; 2017 Mar; 25(3):572-579. PubMed ID: 28273479
[TBL] [Abstract][Full Text] [Related]
32. Applications of Quantitative Systems Pharmacology in Model-Informed Drug Discovery: Perspective on Impact and Opportunities.
Bradshaw EL; Spilker ME; Zang R; Bansal L; He H; Jones RDO; Le K; Penney M; Schuck E; Topp B; Tsai A; Xu C; Nijsen MJMA; Chan JR
CPT Pharmacometrics Syst Pharmacol; 2019 Nov; 8(11):777-791. PubMed ID: 31535440
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic variations in cancer patients with liver dysfunction: applications and challenges of pharmacometabolomics.
Aboel Dahab A; El-Hag D; Moutamed GM; Aboel Dahab S; Abuknesha R; Smith NW
Cancer Chemother Pharmacol; 2016 Sep; 78(3):465-89. PubMed ID: 27061417
[TBL] [Abstract][Full Text] [Related]
34. Functional mapping of drug response with pharmacodynamic-pharmacokinetic principles.
Ahn K; Luo J; Berg A; Keefe D; Wu R
Trends Pharmacol Sci; 2010 Jul; 31(7):306-11. PubMed ID: 20488563
[TBL] [Abstract][Full Text] [Related]
35. Enhancing the discovery and development of immunotherapies for cancer using quantitative and systems pharmacology: Interleukin-12 as a case study.
Klinke DJ
J Immunother Cancer; 2015; 3():27. PubMed ID: 26082838
[TBL] [Abstract][Full Text] [Related]
36. Pharmacometabonomics: The Prediction of Drug Effects Using Metabolic Profiling.
Everett JR
Handb Exp Pharmacol; 2019; 260():263-299. PubMed ID: 31823071
[TBL] [Abstract][Full Text] [Related]
37. GPS for QSP: A Summary of the ACoP6 Symposium on Quantitative Systems Pharmacology and a Stage for Near-Term Efforts in the Field.
Musante CJ; Abernethy DR; Allerheiligen SR; Lauffenburger DA; Zager MG
CPT Pharmacometrics Syst Pharmacol; 2016 Sep; 5(9):449-51. PubMed ID: 27639191
[TBL] [Abstract][Full Text] [Related]
38. Systems Pharmacology in Small Molecular Drug Discovery.
Zhou W; Wang Y; Lu A; Zhang G
Int J Mol Sci; 2016 Feb; 17(2):246. PubMed ID: 26901192
[TBL] [Abstract][Full Text] [Related]
39. Metabolic Profiling and Phenotyping of Central Nervous System Diseases: Metabolites Bring Insights into Brain Dysfunctions.
Dumas ME; Davidovic L
J Neuroimmune Pharmacol; 2015 Sep; 10(3):402-24. PubMed ID: 25616565
[TBL] [Abstract][Full Text] [Related]
40. Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine.
Kohler I; Hankemeier T; van der Graaf PH; Knibbe CAJ; van Hasselt JGC
Eur J Pharm Sci; 2017 Nov; 109S():S15-S21. PubMed ID: 28502671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
